← Leaderboards
C. Noel Bairey Merz
La Biomed Res Inst/ Harbor Ucla Med Ctr
$16,199,798
Attributed
$18,660,525
Total exposure
23
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,404,564 · 24
By mechanism
U54$14,854,676 · 8
R01$10,407,292 · 5
M01$1,094,347 · 10
UG3$1,048,249 · 1
Top collaborators
- Susan Cheng7 shared
- Carl J Pepine5 shared
- Mario Fl Gaudino1 shared
- Ruth Marie Masterson Creber1 shared
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanFunctional DisorderResourcesEvaluationBlood VesselsInflammatoryFemaleMicrovascular DysfunctionFundingStructureHeart FailureChronicEfracPreservationResearch PersonnelDisease OutcomeInflammationMedicalAlzheimer&AposEnrollmentWomen&AposBrainProspectiveHeart Function
Grant awards (60)
The Microvascular Aging Effects - Women's Evaluation of Systemic aging Tenacity in Heart, Brain and Frailty (MAE-WEST HBF) ("You are never too old to become younger!")$1,497,502
U54 · FY2025 · AG · contact PI
1/2 Randomized comparison of the Outcomes of single vs Multiple Arterial grafts trial in Women (ROMA:Women)$1,048,249
UG3 · FY2025 · HL
The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)$1,663,829
U54 · FY2024 · AG
MAE-WEST SCORE Project 2 Clinical$391,584
U54 · FY2024 · AG · contact PI
MAE-WEST SCORE Leadership Administrative Core$206,353
U54 · FY2024 · AG · contact PI
The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)$164,704
U54 · FY2024 · AG
MAE-WEST SCORE Career Enhance Core$146,994
U54 · FY2024 · AG · contact PI
The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)$1,658,363
U54 · FY2023 · AG
Women's Ischemia Syndrome Evaluation (WISE) - Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF)$616,836
R01 · FY2023 · HL · contact PI
MAE-WEST SCORE Project 2 Clinical$584,247
U54 · FY2023 · AG · contact PI
MAE-WEST SCORE Leadership Administrative Core$187,186
U54 · FY2023 · AG · contact PI
The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)$164,704
U54 · FY2023 · AG
MAE-WEST SCORE Career Enhance Core$117,859
U54 · FY2023 · AG · contact PI
The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)$1,654,296
U54 · FY2022 · AG
MAE-WEST SCORE Project 2 Clinical$728,540
U54 · FY2022 · AG · contact PI
Women's Ischemia Syndrome Evaluation (WISE) - Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF)$661,191
R01 · FY2022 · HL · contact PI
Microvascular Disease Burden and Cerebral Small Vessel Disease: Relations to Neurocognition$438,723
R01 · FY2022 · HL · contact PI
MAE-WEST SCORE Leadership Administrative Core$228,113
U54 · FY2022 · AG · contact PI
MAE-WEST SCORE Career Enhance Core$142,458
U54 · FY2022 · AG · contact PI
The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)$1,670,170
U54 · FY2021 · AG
MAE-WEST SCORE Project 2 Clinical$732,860
U54 · FY2021 · AG · contact PI
Women's Ischemia Syndrome Evaluation (WISE) - Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF)$672,969
R01 · FY2021 · HL · contact PI
MAE-WEST SCORE Leadership Administrative Core$230,655
U54 · FY2021 · AG · contact PI
MAE-WEST SCORE Career Enhance Core$142,913
U54 · FY2021 · AG · contact PI
The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)$1,767,973
U54 · FY2020 · AG
Women's Ischemia Syndrome Evaluation (WISE) - Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF)$670,593
R01 · FY2020 · HL · contact PI
MAE-WEST SCORE Project 2 Clinical$489,013
U54 · FY2020 · AG · contact PI
MAE-WEST SCORE Leadership Administrative Core$195,212
U54 · FY2020 · AG · contact PI
MAE-WEST SCORE Career Enhance Core$89,148
U54 · FY2020 · AG · contact PI
Women's Ischemia Syndrome Evaluation (WISE) - Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF)$688,131
R01 · FY2019 · HL · contact PI
Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction$500,000
R01 · FY2013 · HL · contact PI
Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction$760,707
R01 · FY2011 · HL · contact PI
Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction$745,442
R01 · FY2010 · HL · contact PI
THE IMPACT OF TRADITIONAL ACUPUNCTURE ON MENOPAUSAL VASOMOTOR SYMPTOMS$44,233
M01 · FY2010 · RR · contact PI
ESTROGEN DEFICIENCY AND CARDIOVASCULAR DISEASE IN PREMENOPAUSAL WOMEN$21,196
M01 · FY2010 · RR · contact PI
VARIATION IN RECOVERY: ROLE OF GENDER ON OUTCOMES IN ACUTE MYOCARDIAL INFARCTION$10,138
M01 · FY2010 · RR · contact PI
Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction$741,804
R01 · FY2009 · HL · contact PI
Effects of Traditional Acupuncture on Mechanisms of CHD$162,500
R01 · FY2009 · AT · contact PI
ESTROGEN DEFICIENCY AND CARDIOVASCULAR DISEASE IN PREMENOPAUSAL WOMEN$19,546
M01 · FY2009 · RR · contact PI
Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction$775,836
R01 · FY2008 · HL · contact PI
Effects of Traditional Acupuncture on Mechanisms of CHD$577,558
R01 · FY2008 · AT · contact PI
Effects of Traditional Acupuncture on Mechanisms of CHD$23,210
R01 · FY2008 · AT · contact PI
Effects of Traditional Acupuncture on Mechanisms of CHD$446,991
R01 · FY2007 · AT · contact PI
ESTROGEN DEFICIENCY AND CARDIOVASCULAR DISEASE IN PREMENOPAUSAL WOMEN$2,878
M01 · FY2007 · RR · contact PI
Effects of Traditional Acupuncture on Mechanisms of CHD$438,734
R01 · FY2006 · AT · contact PI
ESTROGEN DEFICIENCY AND CORONARY ARTERY DISEASE IN PREMENOPAUSAL WOMEN$40,516
M01 · FY2006 · RR · contact PI
Effects of Traditional Acupuncture on Mechanisms of CHD$467,600
R01 · FY2005 · AT
Reproductive Hormones and Pre-Clinical CVD in Women$153,000
R01 · FY2004 · HL
Reproductive Hormones and Pre-Clinical CVD in Women$153,000
R01 · FY2003 · HL
WOMEN'S ISCHEMIC SYMPTOM EVALUATION (WISE)$237,978
M01 · FY2001 · RR
IMPACT OF ORAL MAGNESIUM ON CARDIAC FUNCTIONAL CAPACITY CAD PATIENTS$237,978
M01 · FY2001 · RR
LESCOL EFFECT OF LESCOL &MAGNITUDE OF MYOCARDIAL ISCHEMIA CHD$237,978
M01 · FY2001 · RR
ATORVA 54 OPEN LABEL ASSESSMENT$237,978
M01 · FY2001 · RR
EFFECTS OF MEDITATION ON MECHANISMS OF CHD$712,467
R01 · FY2000 · AT
WOMEN'S ISCHEMIC SYMPTOM EVALUATION (WISE)$982
M01 · FY2000 · RR
IMPACT OF ORAL MAGNESIUM ON CARDIAC FUNCTIONAL CAPACITY CAD PATIENTS$982
M01 · FY2000 · RR
LESCOL EFFECT OF LESCOL &MAGNITUDE OF MYOCARDIAL ISCHEMIA CHD$982
M01 · FY2000 · RR
ATORVA 54 OPEN LABEL ASSESSMENT$982
M01 · FY2000 · RR
WOMEN'S ISCHEMIC SYMPTOM EVALUATION (WISE)$0
M01 · FY2000 · RR
WOMEN'S ISCHEMIC SYMPTOM EVALUATION (WISE)$0
M01 · FY2000 · RR